News headlines about Female Health (NASDAQ:VERU) have been trending somewhat positive on Sunday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Female Health earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave headlines about the company an impact score of 44.6289070274364 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news headlines that may have impacted Accern’s analysis:
- Female Health Company (The) (VERU) Given a $5.00 Price Target by HC Wainwright Analysts (americanbankingnews.com)
- Uber’s $100,000 cyberattack cover-up is just the latest in a long list of scandals (businessinsider.com)
- WOMEN IN INSURANCE & FINANCIAL SERVICES ANNOUNCES 2017 AWARD WINNERS (readme.readmedia.com)
- The Anti-GMO Movement Has A Social Justice Problem (forbes.com)
- Women breach the world of Big Oil (nola.com)
Several equities research analysts recently weighed in on VERU shares. ValuEngine cut Female Health from a “hold” rating to a “sell” rating in a research note on Tuesday, October 31st. HC Wainwright set a $5.00 price objective on Female Health and gave the company a “buy” rating in a research note on Tuesday, November 14th. Finally, Zacks Investment Research upgraded Female Health from a “hold” rating to a “buy” rating and set a $2.50 price objective for the company in a research note on Wednesday, September 27th.
Shares of Female Health (NASDAQ VERU) opened at $1.20 on Friday. Female Health has a 52 week low of $0.90 and a 52 week high of $3.00.
In other news, insider Mitchell Shuster Steiner acquired 100,000 shares of Female Health stock in a transaction on Friday, September 15th. The stock was bought at an average price of $1.63 per share, for a total transaction of $163,000.00. Following the completion of the purchase, the insider now owns 7,764,767 shares in the company, valued at $12,656,570.21. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry Fisch acquired 34,250 shares of Female Health stock in a transaction on Wednesday, September 13th. The stock was purchased at an average price of $1.51 per share, with a total value of $51,717.50. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 139,875 shares of company stock valued at $224,055. 10.90% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://transcriptdaily.com/2017/11/26/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-female-health-veru-share-price.html.
Female Health Company Profile
Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Ratings for Female Health Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Female Health Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.